GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 135 filers reported holding GOSSAMER BIO INC in Q4 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $163,838 | +6851.1% | 196,732 | +9916.9% | 0.00% | – |
Q2 2023 | $2,357 | +33.6% | 1,964 | +40.3% | 0.00% | – |
Q1 2023 | $1,764 | -99.9% | 1,400 | -99.9% | 0.00% | -100.0% |
Q4 2022 | $2,616,033 | -79.7% | 1,205,545 | +12.1% | 0.00% | -77.8% |
Q3 2022 | $12,880,000 | +75.9% | 1,075,097 | +22.9% | 0.01% | +80.0% |
Q2 2022 | $7,322,000 | +1171.2% | 874,786 | +1217.3% | 0.01% | – |
Q1 2022 | $576,000 | -66.7% | 66,409 | -56.5% | 0.00% | -100.0% |
Q4 2021 | $1,728,000 | -25.6% | 152,785 | -17.3% | 0.00% | 0.0% |
Q3 2021 | $2,323,000 | +60.7% | 184,778 | +3.7% | 0.00% | 0.0% |
Q2 2021 | $1,446,000 | -28.2% | 178,118 | -18.2% | 0.00% | 0.0% |
Q1 2021 | $2,013,000 | +1084.1% | 217,633 | +1139.7% | 0.00% | – |
Q4 2020 | $170,000 | +104.8% | 17,556 | +163.3% | 0.00% | – |
Q3 2020 | $83,000 | -82.6% | 6,667 | -81.8% | 0.00% | – |
Q2 2020 | $476,000 | +31.9% | 36,626 | +3.0% | 0.00% | – |
Q1 2020 | $361,000 | -40.5% | 35,558 | -8.4% | 0.00% | – |
Q4 2019 | $607,000 | +1739.4% | 38,836 | +1850.6% | 0.00% | – |
Q3 2019 | $33,000 | -76.4% | 1,991 | -68.3% | 0.00% | – |
Q2 2019 | $140,000 | +112.1% | 6,279 | +105.1% | 0.00% | – |
Q1 2019 | $66,000 | – | 3,061 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 3,164,835 | $27,471,000 | 5.62% |
Kynam Capital Management, LP | 1,832,704 | $15,908,000 | 5.16% |
Octagon Capital Advisors LP | 2,563,138 | $22,248,000 | 4.81% |
Ally Bridge Group (NY) LLC | 450,000 | $3,906,000 | 2.90% |
HHLR ADVISORS, LTD. | 7,420,974 | $64,414,000 | 1.34% |
Palo Alto Investors LP | 1,756,757 | $15,249,000 | 1.18% |
Boxer Capital, LLC | 2,462,358 | $21,373,000 | 1.10% |
Ikarian Capital, LLC | 775,315 | $6,730,000 | 0.88% |
Artal Group S.A. | 2,358,968 | $20,476,000 | 0.86% |
Birchview Capital, LP | 129,088 | $1,120,000 | 0.81% |